In this study, we have defined the molecular mechanism by which Mxi1 regulates lung cancer progression, and shown that Mxi1 was significantly downregulated in lung tumors and the downregulation was associated with poor prognosis. The gene discussed is MXI1; the disease is lung carcinoma.